首页|期刊导航|肿瘤预防与治疗|有肿瘤病史的年龄相关性白内障患者术后干眼的流行病学特征及可干预危险因素分析

有肿瘤病史的年龄相关性白内障患者术后干眼的流行病学特征及可干预危险因素分析OA

Epidemiological Characteristics and Modifiable Risk Factors for Postoper-ative Dry Eye in Age-Related Cataract Patients with a History of Malig-nancy

中文摘要英文摘要

目的:探讨有肿瘤病史或正在接受抗肿瘤治疗的年龄相关性白内障患者白内障摘除术后眼手术相关性干眼的流行病学特征及可干预危险因素,为该特殊人群术后干眼的防治提供参考依据.方法:基于真实世界临床数据的回顾性观察性研究设计,连续纳入 2022 年 6 月至 2025 年 6 月期间自贡市第一人民医院眼科收治的有肿瘤病史或正在接受抗肿瘤治疗的 204 例行白内障超声乳化摘除联合人工晶状体植入术的单眼年龄相关性白内障患者作为研究对象,记录患者的一般资料、肿瘤相关病史、手术及围手术期用药等临床资料,分别于术前 3 d 及术后 1 d、7 d、14 d、30 d、90 d 进行中国干眼问卷和眼表疾病指数量表评分、裂隙灯显微镜检查、泪河高度测定、泪膜破裂时间检测、角膜荧光素染色评分、泪液分泌量检测(Schirmer I 试验)、睑板腺形态和功能评估,评估眼手术相关性干眼的发生情况、时间分布,对是否发生干眼的 2 组患者进行 1:1 倾向性评分匹配(propensity score matching,PSM),采用多因素Logistic 回归模型分析有肿瘤病史的年龄相关性白内障患者术后发生眼手术相关性干眼的可干预危险因素.结果:204 例患者中,78 例(38.24%)发生眼手术相关性干眼;干眼主要发生于术后第 1~7 天(64 例,占 82.05%),术后第 7天达高峰(50 例,24.51%).单因素分析显示,性别、年龄、肿瘤类型、抗肿瘤治疗方式、抗肿瘤治疗累计时长、全身免疫系统疾病史、糖尿病史、甲状腺功能异常病史、高海拔低湿度环境、长时间注视电子屏幕、睑板腺功能障碍、眼表负荷试验阳性、睑板腺分泌评分、睑脂黏度分级、结膜松弛分级、佩戴角膜接触镜、手术时间、使用含防腐剂滴眼液、多种药物联合应用与术后干眼发生相关(均 P<0.05).经 PSM 匹配性别、年龄、既往眼部手术史后,多因素 Logistic 回归分析显示:头颈部放疗(OR=4.925,95%CI:2.038~11.903)、化疗(OR=4.087,95%CI:1.782~9.374)、抗肿瘤治疗累计时长≥12 个月(OR=3.722,95%CI:1.746~7.935)、糖尿病史(OR=5.512,95%CI:2.215~13.718)、睑板腺功能障碍(OR=4.038,95%CI:1.586~10.278)、睑脂黏度分级 3~5 级(OR=10.124,95%CI:3.786~27.066)、结膜松弛分级 3 级(OR=8.736,95%CI:3.231~23.618)、佩戴角膜接触镜(OR=10.458,95%CI:3.496~31.289)、使用含防腐剂滴眼液(OR=1.166,95%CI:1.055~1.289)、多种药物联合使用(OR=10.015,95%CI:3.438~29.179)是术后干眼的独立可干预危险因素(均 P<0.05).结论:有肿瘤病史或正在接受抗肿瘤治疗的年龄相关性白内障患者术后干眼发生率为 38.24%,术后第 1~7 天为关键窗口期.头颈部放疗、化疗、长疗程抗肿瘤治疗及围手术期眼表相关因素是术后干眼的重要可干预危险因素,临床需对接受头颈部放疗、化疗、合并糖尿病、重度睑板腺功能障碍及睑脂黏度异常患者术前开展眼表功能筛查与预处理,术后 1 周内强化干眼防控措施.

Objective:To investigate the epidemiological characteristics and modifiable risk factors for surgery-related dry eye following cataract extraction in age-related cataract patients with a history of malignancy or those undergoing active antitu-mor therapy,and to provide a reference for the prevention and management of postoperative dry eye in this specific popula-tion.Methods:In this retrospective observational study based on real-world clinical data,a total of 204 monocular age-relat-ed cataract patients with a history of malignancy or receiving active antitumor therapy,who underwent phacoemulsification combined with intraocular lens implantation at the Department of Ophthalmology,Zigong First People's Hospital,between June 2022 and June 2025,were consecutively enrolled.General demographic data,malignancy-related history,surgical re-cords,and perioperative medication profiles were documented.Assessments were conducted at 3 days preoperatively and at 1,7,14,30,and 90 days postoperatively,including the Chinese Dry Eye Questionnaire and Ocular Surface Disease Index scoring,slit-lamp biomicroscopy,tear meniscus height measurement,tear film break-up time testing,corneal fluorescein staining scoring,Schirmer I test,and meibomian gland morphology and function evaluation.The incidence and temporal dis-tribution of surgery-related dry eye were evaluated.Patients with and without postoperative dry eye were matched at a 1:1 ratio using propensity score matching(PSM).Multivariable logistic regression analysis was employed to identify modifiable risk factors for surgery-related dry eye in age-related cataract patients with a history of malignancy.Results:Among the 204 patients,78(38.24%)developed surgery-related dry eye.The onset of dry eye predominantly occurred between postopera-tive days 1 and 7(64 cases,accounting for 82.05%),with a peak incidence on day 7(50 cases,24.51%).Univariate a-nalysis revealed that sex,age,tumor type,antitumor treatment modality,cumulative duration of antitumor therapy,history of systemic immune diseases,diabetes mellitus,thyroid dysfunction,high-altitude low-humidity environment,prolonged elec-tronic screen use,meibomian gland dysfunction,positive Ocular Surface Staining Test,meibomian gland secretion score,meibum viscosity grade,conjunctivochalasis grade,contact lens wear,surgical duration,use of preservative-containing eye drops,and combined use of multiple ophthalmic medications were associated with postoperative dry eye(all P<0.05).Af-ter PSM for sex,age,and history of prior ocular surgery,multivariable logistic regression analysis identified the following in-dependent modifiable risk factors for postoperative dry eye:head and neck radiotherapy(OR=4.925,95%CI:2.038~11.903),chemotherapy(OR=4.087,95%CI:1.782~9.374),cumulative antitumor therapy duration≥12 months(OR=3.722,95%CI:1.746~7.935),history of diabetes mellitus(OR=5.512,95%CI:2.215~13.718),mei-bomian gland dysfunction(OR=4.038,95%CI:1.586~10.278),meibum viscosity grade 3~5(OR=10.124,95%CI:3.786~27.066),conjunctivochalasis grade 3(OR=8.736,95%CI:3.231~23.618),contact lens wear(OR=10.458,95%CI:3.496~31.289),use of preservative-containing eye drops(OR=1.166,95%CI:1.055~1.289),and combined use of multiple ophthalmic medications(OR=10.015,95%CI:3.438~29.179)(all P<0.05).Con-clusion:The incidence of postoperative dry eye in age-related cataract patients with a history of malignancy or undergoing ac-tive antitumor therapy is 38.24%,with the first 7 days postoperatively constituting a critical window.Head and neck radio-therapy,chemotherapy,prolonged antitumor therapy,and perioperative ocular surface-related factors are significant modifia-ble risk factors for postoperative dry eye.Preoperative ocular surface screening and preconditioning,along with intensified dry eye prevention during the first postoperative week,are recommended for patients receiving radiotherapy or chemotherapy,those with diabetes,and those with severe meibomian gland dysfunction or abnormal meibum viscosity.

彭璟;曾洪波;杨秀丽;刘利丽;张晓彧;甘榆讯

643000 四川 自贡,自贡市第一人民医院·自贡市医学科学院 眼科643000 四川 自贡,自贡市第一人民医院·自贡市医学科学院 眼科643000 四川 自贡,自贡市第一人民医院·自贡市医学科学院 眼科643000 四川 自贡,自贡市第一人民医院·自贡市医学科学院 眼科643000 四川 自贡,自贡市第一人民医院·自贡市医学科学院 眼科643000 四川 自贡,自贡市第一人民医院·自贡市医学科学院 眼科

医药卫生

肿瘤疾病史年龄相关性白内障眼手术相关性干眼发病率可干预危险因素倾向性评分匹配法睑板腺功能障碍

History of malignancyAge-related cataractSurgery-related dry eyeIncidenceModifiable risk factorsPropensity score matchingMeibomian gland dysfunction

《肿瘤预防与治疗》 2026 (8)

654-665,12

自贡市科技计划重点研发项目(编号:2023YLWS06) This study was supported by grants from Zigong Science and Technology Bureau(No.2023YLWS06).

10.3969/j.issn.1674-0904.2026.08.005

评论